Cargando…
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
[Image: see text] Antibody–drug conjugates (ADCs) combine the specificity of antibodies with the potency of small molecules to create targeted drugs. Despite the simplicity of this concept, generation of clinically successful ADCs has been very difficult. Over the past several decades, scientists ha...
Autores principales: | Agarwal, Paresh, Bertozzi, Carolyn R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335810/ https://www.ncbi.nlm.nih.gov/pubmed/25494884 http://dx.doi.org/10.1021/bc5004982 |
Ejemplares similares
-
A Special Virtual
Issue Celebrating the 2022 Nobel Prize in Chemistry for the Development
of Click Chemistry and Bioorthogonal Chemistry
por: Bertozzi, Carolyn
Publicado: (2022) -
Probing the Mycobacterial
Trehalome with Bioorthogonal
Chemistry
por: Swarts, Benjamin M., et al.
Publicado: (2012) -
Construction of homogeneous antibody–drug conjugates using site-selective protein chemistry
por: Akkapeddi, Padma, et al.
Publicado: (2016) -
Bioorthogonal site-selective conjugation of fluorescent dyes to antibodies: method and potential applications
por: Grossenbacher, Philipp, et al.
Publicado: (2022) -
A Bioorthogonal Quadricyclane Ligation
por: Sletten, Ellen M., et al.
Publicado: (2011)